Human autopsy study of drug-eluting stents restenosis: Histomorphological predictors and neointimal characteristics

European Heart Journal

Volumn 34, Issue 42, 2013, Pages 3304-3313

  Nakano, Masataka ^a   Otsuka, Fumiyuki ^a   Yahagi, Kazuyuki ^a   Sakakura, Kenichi ^a   Kutys, Robert ^a   Ladich, Elena R ^a   Finn, Aloke V ^b   Kolodgie, Frank D ^a   Virmani, Renu ^a  

^a CVPATH INSTITUTE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Drug eluting stent; Histology; Human autopsy; Neointima; Restenosis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; COLLAGEN TYPE 3; EVEROLIMUS; PACLITAXEL; PROTEOGLYCAN; RAPAMYCIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROMA; AUTOPSY; BARE METAL STENT; CAUSE OF DEATH; CELL DENSITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DRUG ELUTING STENT; DYSLIPIDEMIA; EXTRACELLULAR MATRIX; FEMALE; FIBROATHEROMA; HEART INFARCTION; HEART MUSCLE CELL; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN-STENT RESTENOSIS; KIDNEY FAILURE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEOINTIMA; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; RESTENOSIS; SMOKING; SMOOTH MUSCLE FIBER; STABLE ANGINA PECTORIS; T LYMPHOCYTE;

DRUG-ELUTING STENT; HISTOLOGY; HUMAN AUTOPSY; NEOINTIMA; RESTENOSIS;

AUTOPSY; CORONARY RESTENOSIS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; NEOINTIMA; PLAQUE, ATHEROSCLEROTIC; PROSTHESIS FAILURE; STENTS;

EID: 84890536211     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht241     Document Type: Article

References (24)

1. Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T,Wallentin L. Long-Term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-1019.
2. Lagerqvist B, Carlsson J, Frobert O, Lindback J, Schersten F, Stenestrand U, James SK. Stent thrombosis in Sweden: A report from the Swedish Coronary Angiography and Angioplasty Registry. Circ Cardiovasc Interv 2009;2:401-408.
3. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
4. Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, Lee SW, Kim YH, Whan Lee C, Park SW, Park SJ. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation. Circulation 2011; 123:2954-2963.
5. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-2441.
6. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: shouldwebe cautious?. Circulation 2004;109:701-705.
7. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
8. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002; 105:2974-2980.
9. Farb A, Kolodgie FD, Hwang JY, Burke AP, Tefera K, Weber DK, Wight TN, Virmani R. Extracellular matrix changes in stented human coronary arteries. Circulation 2004;110:940-947.
10. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A. Adventitial remodeling after coronary arterial injury. Circulation 1996;93:340-348.
11. Hwang CW, Wu D, Edelman ER. Physiological transport forces govern drug distribution for stent-based delivery. Circulation 2001;104:600-605.
12. Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda T, Costa RA, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps E, Collins MB, Colombo A, Stone GW, Leon MB, Moses JW. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 2004;110:3430-3434.
13. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 19:267-274.
14. Wysocki SJ, Zheng MH, Smith A, Norman PE. Vascular endothelial growth factor (VEGF) expression during arterial repair in the pig. Eur J Vasc Endovasc Surg 1998; 15:225-230.
15. Hausner EA, Orsini JA, Foster LL, Modzelewski TC, Merrill JJ, Perkowski SZ, Slee A. Vascular endothelial growth factor in porcine coronary arteries following balloon angioplasty. J Invest Surg 1999;12:15-23.
16. Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, Sato Y, Hamasaki N, Nosaka H. Three-year follow-up after implantation of metallic coronary-Artery stents. N Engl J Med 1996;334:561-566.
17. Park DW, Hong MK, Mintz GS, Lee CW, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ,Weissman NJ, Park SW, Park SJ. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late 'catch-up' phenomenon from ASPECT Study. J Am Coll Cardiol 2006;48:2432-2439.
18. Kang SJ, Park DW, Mintz GS, Lee SW, Kim YH, Lee CW, Han KH, Kim JJ, Park SW, Park SJ. Long-Term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis. Am J Cardiol 2010; 105:1402-1408.
19. Williams KJ, Tabas I. The response-To-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995;15:551-561.
20. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011;57:1314-1322.
21. Boren J, Lee I, Zhu W, Arnold K, Taylor S, Innerarity TL. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. J Clin Invest 1998;101:1084-1093.
22. Flood C, Gustafsson M, Richardson PE, Harvey SC, Segrest JP, Boren J. Identification of the proteoglycan binding site in apolipoprotein B48. J Biol Chem 2002; 277:32228-32233.
23. Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, Boren J. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002;417:750-754.
24. Merrilees MJ, Beaumont BW, Braun KR, Thomas AC, Kang I, Hinek A, Passi A, Wight TN. Neointima formed by arterial smooth muscle cells expressing versican variant V3 is resistant to lipid and macrophage accumulation. Arterioscler Thromb Vasc Biol 2011;31:1309-1316.